FMP
Global Cord Blood Corporation
CO
NYSE
Inactive Equity
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.
2.99 USD
0 (0%)
Operating Data
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
5.16M
6.28M
7.17M
8.76M
8.83M
10.12M
11.61M
13.32M
15.28M
17.53M
Revenue %
-
21.69
14.24
22.1
0.79
14.7
14.7
14.7
14.7
Ebitda
-14.06M
-34.36M
-49.03M
-80.83M
-77.22M
-10.12M
-11.61M
-13.32M
-15.28M
-17.53M
Ebitda %
-272.54
-547.19
-683.59
-922.96
-874.85
-100
-100
-100
-100
Ebit
-16.79M
-36.96M
-51.37M
-82.68M
-77.22M
-10.12M
-11.61M
-13.32M
-15.28M
-17.53M
Ebit %
-325.37
-588.63
-716.12
-944.03
-874.85
-100
-100
-100
-100
Depreciation
2.73M
2.6M
2.33M
1.84M
-
2.99M
3.43M
3.94M
4.52M
5.18M
Depreciation %
52.83
41.44
32.52
21.07
-
29.57
29.57
29.57
29.57
Balance Sheet
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Total Cash
21.34M
9.48M
7.07M
41.31M
177.98M
10.09M
11.58M
13.28M
15.23M
17.47M
Total Cash %
413.47
151.03
98.49
471.65
2.02k
99.7
99.7
99.7
99.7
Receivables
16.18M
438k
815k
1.74M
1.42M
3.12M
3.58M
4.11M
4.71M
5.41M
Receivables %
313.66
6.98
11.36
19.84
16.09
30.85
30.85
30.85
30.85
Inventories
2.52M
2.11M
2.2M
2.08M
1.69M
3.16M
3.62M
4.16M
4.77M
5.47M
Inventories %
48.86
33.67
30.61
23.73
19.1
31.19
31.19
31.19
31.19
Payable
2.18M
2.11M
3.76M
1.47M
815k
3.12M
3.58M
4.1M
4.71M
5.4M
Payable %
42.17
33.59
52.36
16.73
9.23
30.82
30.82
30.82
30.82
Cap Ex
-789k
-2M
-498k
-630k
-2.11M
-1.72M
-1.98M
-2.27M
-2.6M
-2.98M
Cap Ex %
-15.29
-31.84
-6.94
-7.19
-23.86
-17.02
-17.02
-17.02
-17.02
Weighted Average Cost Of Capital
Price
11.18
Beta
Diluted Shares Outstanding
192.13M
Costof Debt
4.11
Tax Rate
After Tax Cost Of Debt
4.11
Risk Free Rate
Market Risk Premium
Cost Of Equity
Total Debt
8.25M
Total Equity
2.15B
Total Capital
2.16B
Debt Weighting
0.38
Equity Weighting
99.62
Wacc
9.35
Build Up Free Cash Flow
Year
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
Revenue
5.16M
6.28M
7.17M
8.76M
8.83M
10.12M
11.61M
13.32M
15.28M
17.53M
Ebitda
-14.06M
-34.36M
-49.03M
-80.83M
-77.22M
-10.12M
-11.61M
-13.32M
-15.28M
-17.53M
Ebit
-16.79M
-36.96M
-51.37M
-82.68M
-77.22M
-10.12M
-11.61M
-13.32M
-15.28M
-17.53M
Tax Rate
-
-
-
-
-
-
-
-
-
-
Ebiat
-30.57M
-39.92M
-38.84M
-82.68M
-77.22M
-9.63M
-11.05M
-12.67M
-14.53M
-16.67M
Depreciation
2.73M
2.6M
2.33M
1.84M
-
2.99M
3.43M
3.94M
4.52M
5.18M
Receivables
16.18M
438k
815k
1.74M
1.42M
3.12M
3.58M
4.11M
4.71M
5.41M
Inventories
2.52M
2.11M
2.2M
2.08M
1.69M
3.16M
3.62M
4.16M
4.77M
5.47M
Payable
2.18M
2.11M
3.76M
1.47M
815k
3.12M
3.58M
4.1M
4.71M
5.4M
Cap Ex
-789k
-2M
-498k
-630k
-2.11M
-1.72M
-1.98M
-2.27M
-2.6M
-2.98M
Ufcf
-45.17M
-23.23M
-35.82M
-84.56M
-79.27M
-9.23M
-10.05M
-11.53M
-13.23M
-15.17M
Wacc
9.35
9.35
9.35
9.35
9.35
Pv Ufcf
-8.44M
-8.41M
-8.82M
-9.25M
-9.7M
Sum Pv Ufcf
-44.63M
Terminal Value
Growth In Perpetuity Method
Long Term Growth Rate
Wacc
9.35
Free Cash Flow T1
-15.48M
Terminal Value
-210.65M
Present Terminal Value
-134.75M
Intrinsic Value
Enterprise Value
-179.38M
Net Debt
-169.73M
Equity Value
-9.65M
Diluted Shares Outstanding
192.13M
Equity Value Per Share
-0.05
Projected DCF
-0.05022866 223.582%
